Calliditas Therapeutics AB (publ) logo

Calliditas Therapeutics AB (publ) CALT

$ 40.0 -0.1%

Quarterly report 2022-Q2
added 08-19-2022

report update icon

Country

schwedenSchweden

IPO year

2020

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Ms. Renee Aguiar-Lucander

Employees in the company

23

Shares

50.8 M

Market Cap[1]

$ 2.03 B

EBITDA (LTM)

$ -585 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.